These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
693 related articles for article (PubMed ID: 26481468)
1. Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. Goyanes A; Chang H; Sedough D; Hatton GB; Wang J; Buanz A; Gaisford S; Basit AW Int J Pharm; 2015 Dec; 496(2):414-20. PubMed ID: 26481468 [TBL] [Abstract][Full Text] [Related]
2. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178 [TBL] [Abstract][Full Text] [Related]
3. Fused-filament 3D printing (3DP) for fabrication of tablets. Goyanes A; Buanz AB; Basit AW; Gaisford S Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937 [TBL] [Abstract][Full Text] [Related]
4. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related]
5. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674 [TBL] [Abstract][Full Text] [Related]
6. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
7. Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy. Okwuosa TC; Pereira BC; Arafat B; Cieszynska M; Isreb A; Alhnan MA Pharm Res; 2017 Feb; 34(2):427-437. PubMed ID: 27943014 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. Skowyra J; Pietrzak K; Alhnan MA Eur J Pharm Sci; 2015 Feb; 68():11-7. PubMed ID: 25460545 [TBL] [Abstract][Full Text] [Related]
9. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone. Chai X; Chai H; Wang X; Yang J; Li J; Zhao Y; Cai W; Tao T; Xiang X Sci Rep; 2017 Jun; 7(1):2829. PubMed ID: 28588251 [TBL] [Abstract][Full Text] [Related]
10. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
11. Preparation and investigation of controlled-release glipizide novel oral device with three-dimensional printing. Li Q; Wen H; Jia D; Guan X; Pan H; Yang Y; Yu S; Zhu Z; Xiang R; Pan W Int J Pharm; 2017 Jun; 525(1):5-11. PubMed ID: 28377316 [TBL] [Abstract][Full Text] [Related]
12. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535 [TBL] [Abstract][Full Text] [Related]
13. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471 [TBL] [Abstract][Full Text] [Related]
14. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice. Gareb B; Dijkstra G; Kosterink JGW; Frijlink HW Int J Pharm; 2019 Jan; 554():366-375. PubMed ID: 30414898 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients. Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907 [TBL] [Abstract][Full Text] [Related]
16. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability. Solanki NG; Tahsin M; Shah AV; Serajuddin ATM J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279 [TBL] [Abstract][Full Text] [Related]
17. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613 [TBL] [Abstract][Full Text] [Related]
18. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. Krause J; Bogdahn M; Schneider F; Koziolek M; Weitschies W Eur J Pharm Sci; 2019 Dec; 140():105060. PubMed ID: 31499171 [TBL] [Abstract][Full Text] [Related]
19. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing. Zhang P; Xu P; Chung S; Bandari S; Repka MA Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460 [TBL] [Abstract][Full Text] [Related]
20. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]